|
1
|
Identification of relaxin-3/INSL7 as an endogenous ligand for the orphan G-protein-coupled receptor GPCR135.
|
J Biol Chem
|
2003
|
1.39
|
|
2
|
Behavioral characterization of mice lacking histamine H(3) receptors.
|
Mol Pharmacol
|
2002
|
1.26
|
|
3
|
Identification of relaxin-3/INSL7 as a ligand for GPCR142.
|
J Biol Chem
|
2003
|
1.19
|
|
4
|
INSL5 is a high affinity specific agonist for GPCR142 (GPR100).
|
J Biol Chem
|
2004
|
1.12
|
|
5
|
R3(BDelta23 27)R/I5 chimeric peptide, a selective antagonist for GPCR135 and GPCR142 over relaxin receptor LGR7: in vitro and in vivo characterization.
|
J Biol Chem
|
2007
|
1.03
|
|
6
|
Distribution of G-protein-coupled receptor (GPCR)135 binding sites and receptor mRNA in the rat brain suggests a role for relaxin-3 in neuroendocrine and sensory processing.
|
Neuroendocrinology
|
2005
|
0.95
|
|
7
|
Relaxin-3/insulin-like peptide 5 chimeric peptide, a selective ligand for G protein-coupled receptor (GPCR)135 and GPCR142 over leucine-rich repeat-containing G protein-coupled receptor 7.
|
Mol Pharmacol
|
2004
|
0.94
|
|
8
|
Molecular and pharmacological characterization of serotonin 5-HT2A and 5-HT2B receptor subtypes in dog.
|
Eur J Pharmacol
|
2005
|
0.77
|
|
9
|
Recent progress in relaxin-3-related research.
|
Ann N Y Acad Sci
|
2005
|
0.75
|
|
10
|
[Efficacy of intratympanic steroid injection as supplementary or initial treatment for sudden sensorineural hearing loss].
|
Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
|
2015
|
0.75
|